Document is current
Any future updates will be listed below
-
Authors
Pastushenko, Ievgenia
Mauri, Federico
Song, Yura https://orcid.org/0000-0002-1173-9172
de Cock, Florian
Meeusen, Bob
Swedlund, Benjamin https://orcid.org/0000-0002-8264-9342
Impens, Francis https://orcid.org/0000-0003-2886-9616
Van Haver, Delphi https://orcid.org/0000-0002-4659-5631
Opitz, Matthieu
Thery, Manuel https://orcid.org/0000-0002-9968-1779
Bareche, Yacine
Lapouge, Gaelle
Vermeersch, Marjorie
Van Eycke, Yves-Rémi https://orcid.org/0000-0002-7131-1784
Balsat, Cédric
Decaestecker, Christine
Sokolow, Youri
Hassid, Sergio
Perez-Bustillo, Alicia
Agreda-Moreno, Beatriz
Rios-Buceta, Luis
Jaen, Pedro
Redondo, Pedro
Sieira-Gil, Ramon https://orcid.org/0000-0002-6522-5679
Millan-Cayetano, Jose F. https://orcid.org/0000-0003-2481-7800
Sanmatrtin, Onofre
D’Haene, Nicky
Moers, Virginie
Rozzi, Milena
Blondeau, Jeremy
Lemaire, Sophie
Scozzaro, Samuel
Janssens, Veerle https://orcid.org/0000-0002-6772-8448
De Troya, Magdalena
Dubois, Christine
Pérez-Morga, David
Salmon, Isabelle
Sotiriou, Christos https://orcid.org/0000-0002-5745-9977
Helmbacher, Francoise https://orcid.org/0000-0001-6822-1246
Blanpain, Cédric https://orcid.org/0000-0002-4028-4322
- License Information
-
More Information
Article History
Received: 21 January 2019
Accepted: 26 October 2020
First Online: 16 December 2020
Competing interests
: C. Blanpain, I.P. and F.M. are co-inventors on a patent application on the use of SRC inhibitors for the treatment of <i>FAT1</i>-mutated cancers.
